✦ LIBER ✦

Efficacy and safety of recombinant human parathyroid hormone (1–84) in hypoparathyroidism (REPLACE): a double-blind, placebo-controlled, randomised, phase 3 study

✍ Scribed by Mannstadt, Michael; Clarke, Bart L; Vokes, Tamara; Brandi, Maria Luisa; Ranganath, Lakshminarayan; Fraser, William D; Lakatos, Peter; Bajnok, Laszlo; Garceau, Roger; Mosekilde, Leif; Lagast, Hjalmar; Shoback, Dolores; Bilezikian, John P

Book ID: 122527798
Publisher: Elsevier
Year: 2013
Tongue: English
Weight: 342 KB
Volume: 1
Category: Article
ISSN: 2213-8587
DOI: 10.1016/S2213-8587(13)70106-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and safety of a recombinant hep

Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial

✍ Feng-Cai Zhu; Jun Zhang; Xue-Feng Zhang; Cheng Zhou; Zhong-Ze Wang; Shou-Jie Hua 📂 Article 📅 2010 🏛 The Lancet 🌐 English ⚖ 272 KB

A randomised, placebo-controlled, double

A randomised, placebo-controlled, double blind phase III study of the efficacy and safety of recombinant human C1 inhibitor for the treatment of acute attacks in patients with hereditary angioedema

✍ Marco Cicardi; Roberto Perricone; Mauro Cancian; Vincenzo Montinaro; Enrico Cill 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 86 KB

Efficacy and safety of oral fumarate in

Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study

✍ Ludwig Kappos; Ralf Gold; David H Miller; David G MacManus; Eva Havrdova; Volker 📂 Article 📅 2008 🏛 The Lancet 🌐 English ⚖ 209 KB

Safety and efficacy of fingolimod in pat

Safety and efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis (FREEDOMS II): a double-blind, randomised, placebo-controlled, phase 3 trial

✍ Calabresi, Peter A; Radue, Ernst-Wilhelm; Goodin, Douglas; Jeffery, Douglas; Ram 📂 Article 📅 2014 🏛 The Lancet 🌐 English ⚖ 290 KB

Safety and efficacy of suvorexant during

Safety and efficacy of suvorexant during 1-year treatment of insomnia with subsequent abrupt treatment discontinuation: a phase 3 randomised, double-blind, placebo-controlled trial

✍ Michelson, David; Snyder, Ellen; Paradis, Erin; Chengan-Liu, Mary; Snavely, Duan 📂 Article 📅 2014 🏛 The Lancet 🌐 English ⚖ 242 KB

Efficacy and safety of celgosivir in pat

Efficacy and safety of celgosivir in patients with dengue fever (CELADEN): a phase 1b, randomised, double-blind, placebo-controlled, proof-of-concept trial

✍ Low, Jenny G; Sung, Cynthia; Wijaya, Limin; Wei, Yuan; Rathore, Abhay P S; Watan 📂 Article 📅 2014 🏛 The Lancet 🌐 English ⚖ 320 KB